Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicola Zanesi
Selective Targeting of Point-Mutated KRAS Through Artificial microRNAs
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia
Cancer Research
Cancer Research
Oncology
Related publications
Selective Targeting of KRAS Oncogenic Alleles by CRISPR/Cas9 Inhibits Proliferation of Cancer Cells
Scientific Reports
Multidisciplinary
Correction: Selective Targeting of CTNNB1-, KRAS- Or MYC-Driven Cell Growth by Combinations of Existing Drugs
PLoS ONE
Multidisciplinary
Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Epigenetic Alteration of microRNAs in DNMT3B-mutated Patients of ICF Syndrome
Epigenetics
Cancer Research
Medicine
Molecular Biology
Combined Adenovirus-Mediated Artificial microRNAs Targeting Mfgl2, mFas, and mTNFR1 Protect Against Fulminant Hepatic Failure in Mice
PLoS ONE
Multidisciplinary
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers in Oncology
Cancer Research
Oncology
KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination With PI3K Inhibition.
Clinical Cancer Research
Cancer Research
Oncology
Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1
Cell Reports
Biochemistry
Genetics
Molecular Biology
Degradation of ZIKV and DENV Envelope Protein Through Selective Targeting to ERAD Pathway
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology